
Cadrenal Therapeutics, Inc. Common Stock
CVKDHealthcare|Biotechnology|US
$0.98
-0.02 (-2.00%)
DCF Value
$1.73
Tangible Book / Share
$1.40
Cash / Share
$0.82
Next Earnings Report
Mar 17, 2027
EPS est. -$0.86
Financing Filings (last 12 months)
11
Shelf registrations / offering prospectuses — latest Jul 20, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
Oct 7, 2026 · GlobeNewsWire
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
Sep 21, 2026 · GlobeNewsWire
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Sep 3, 2026 · GlobeNewsWire
SEC Filings (78)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 8, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Oct 7, 2026 | 8-K | Material event | DocumentIndex |
| Sep 29, 2026 | 8-K | Material event | DocumentIndex |
| Sep 3, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Aug 31, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Aug 7, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 3, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 3, 2026 | ARS | Annual report to holders | DocumentIndex |
| Aug 3, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 23, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 21, 2026 | 8-K | Material event | DocumentIndex |
| Jul 20, 2026 | EFFECT | DocumentIndex | |
| Jul 20, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 17, 2026 | 8-K | Material event | DocumentIndex |
| Jul 15, 2026 | D | DocumentIndex | |
| Jul 13, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jul 10, 2026 | 8-K | Material event | DocumentIndex |
| Jul 1, 2026 | 8-K | Material event | DocumentIndex |
| Jun 29, 2026 | 8-K | Material event | DocumentIndex |
| Jun 18, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 30, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | EFFECT | DocumentIndex | |
| Apr 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 21, 2026 | S-3 | Shelf registration | DocumentIndex |
| Apr 6, 2026 | D | DocumentIndex | |
| Apr 1, 2026 | 8-K | Material event | DocumentIndex |
| Apr 1, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 12, 2026 | 8-K | Material event | DocumentIndex |
| Feb 24, 2026 | 8-K | Material event | DocumentIndex |
| Jan 2, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Dec 31, 2025 | EFFECT | DocumentIndex | |
| Dec 31, 2025 | D | DocumentIndex | |
| Dec 29, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Dec 23, 2025 | 8-K | Material event | DocumentIndex |